From GlobeNewswire:

Lifecore Biomedical, Inc. received a notice from Nasdaq regarding non-compliance with filing requirements, affecting their stock listing but not trading. The company submitted a plan to regain compliance and has until February 12, 2024 to file the necessary forms. They are diligently working to complete the filings and regain compliance. There is no guarantee that they will be able to do so in time. The announcement was made to comply with Nasdaq listing rules. Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization offering expertise in pharmaceutical development.  They expressed caution regarding forward-looking statements and provided contact information for inquiries.



Read more: Lifecore Biomedical, Inc. Receives Notice from Nasdaq